223 related articles for article (PubMed ID: 16310279)
1. Immunostimulatory CpG-oligodeoxynucleotides (CpG-ODN) induce early hepatic injury, but provide a late window for protection against endotoxin-mediated liver damage.
Slotta JE; Scheuer C; Menger MD; Vollmar B
J Hepatol; 2006 Mar; 44(3):576-85. PubMed ID: 16310279
[TBL] [Abstract][Full Text] [Related]
2. Chloroquine protects mice from challenge with CpG ODN and LPS by decreasing proinflammatory cytokine release.
Hong Z; Jiang Z; Liangxi W; Guofu D; Ping L; Yongling L; Wendong P; Minghai W
Int Immunopharmacol; 2004 Feb; 4(2):223-34. PubMed ID: 14996414
[TBL] [Abstract][Full Text] [Related]
3. Antimalarial artesunate protects sepsis model mice against heat-killed Escherichia coli challenge by decreasing TLR4, TLR9 mRNA expressions and transcription factor NF-kappa B activation.
Li B; Zhang R; Li J; Zhang L; Ding G; Luo P; He S; Dong Y; Jiang W; Lu Y; Cao H; Zheng J; Zhou H
Int Immunopharmacol; 2008 Mar; 8(3):379-89. PubMed ID: 18279792
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of pyrrolidine dithiocarbamate on TNF-alpha-mediated liver injury in two different models of fulminant hepatitis.
Lu JW; Wang H; Yan-Li J; Zhang C; Ning H; Li XY; Zhang H; Duan ZH; Zhao L; Wei W; Xu DX
J Hepatol; 2008 Mar; 48(3):442-52. PubMed ID: 18215436
[TBL] [Abstract][Full Text] [Related]
5. A novel technique for selective NF-kappaB inhibition in Kupffer cells: contrary effects in fulminant hepatitis and ischaemia-reperfusion.
Hoffmann F; Sass G; Zillies J; Zahler S; Tiegs G; Hartkorn A; Fuchs S; Wagner J; Winter G; Coester C; Gerbes AL; Vollmar AM
Gut; 2009 Dec; 58(12):1670-8. PubMed ID: 19470497
[TBL] [Abstract][Full Text] [Related]
6. Immunostimulatory oligodeoxynucleotides induce apoptosis of B cell chronic lymphocytic leukemia cells.
Jahrsdörfer B; Wooldridge JE; Blackwell SE; Taylor CM; Griffith TS; Link BK; Weiner GJ
J Leukoc Biol; 2005 Mar; 77(3):378-87. PubMed ID: 15582984
[TBL] [Abstract][Full Text] [Related]
7. The response of neonatal rat ventricular myocytes to lipopolysaccharide-induced stress.
Hickson-Bick DL; Jones C; Buja LM
Shock; 2006 May; 25(5):546-52. PubMed ID: 16680021
[TBL] [Abstract][Full Text] [Related]
8. [Effects of CpG-ODN combined with HBsAg on the phenotype, function and the activity of NF-kappa B and AP-1 of monocyte-derived dendritic cells in chronic hepatitis B patients].
Xiang XX; Zhou XQ; Xie Q; Yu H; Zhou HJ
Zhonghua Gan Zang Bing Za Zhi; 2008 Feb; 16(2):97-100. PubMed ID: 18304423
[TBL] [Abstract][Full Text] [Related]
9. Glycine attenuates endotoxin-induced liver injury by downregulating TLR4 signaling in Kupffer cells.
Xu FL; You HB; Li XH; Chen XF; Liu ZJ; Gong JP
Am J Surg; 2008 Jul; 196(1):139-48. PubMed ID: 18565339
[TBL] [Abstract][Full Text] [Related]
10. Nuclear factor kappa B decoy oligodeoxynucleotides prevent endotoxin-induced fatal liver failure in a murine model.
Ogushi I; Iimuro Y; Seki E; Son G; Hirano T; Hada T; Tsutsui H; Nakanishi K; Morishita R; Kaneda Y; Fujimoto J
Hepatology; 2003 Aug; 38(2):335-44. PubMed ID: 12883477
[TBL] [Abstract][Full Text] [Related]
11. The newly identified CpG-N ODN208 protects mice from challenge with CpG-S ODN by decreasing TNF-alpha release.
Wang L; Jiang W; Ding G; Cao H; Lu Y; Luo P; Zhou H; Zheng J
Int Immunopharmacol; 2007 May; 7(5):646-55. PubMed ID: 17386412
[TBL] [Abstract][Full Text] [Related]
12. Strategies for enhancing the immunostimulatory effects of CpG oligodeoxynucleotides.
Mutwiri GK; Nichani AK; Babiuk S; Babiuk LA
J Control Release; 2004 May; 97(1):1-17. PubMed ID: 15147800
[TBL] [Abstract][Full Text] [Related]
13. CpG oligonucleotides as adjuvant in therapeutic vaccines against parasitic infections.
Zimmermann S; Dalpke A; Heeg K
Int J Med Microbiol; 2008 Jan; 298(1-2):39-44. PubMed ID: 17716944
[TBL] [Abstract][Full Text] [Related]
14. The immunostimulatory activity of CpG oligonucleotides on microglial N9 cells is affected by a polyguanosine motif.
Zhang Z; Guo K; Schluesener HJ
J Neuroimmunol; 2005 Apr; 161(1-2):68-77. PubMed ID: 15748945
[TBL] [Abstract][Full Text] [Related]
15. Activation of toll-like receptor-9 induces matrix metalloproteinase-9 expression through Akt and tumor necrosis factor-alpha signaling.
Lim EJ; Lee SH; Lee JG; Chin BR; Bae YS; Kim JR; Lee CH; Baek SH
FEBS Lett; 2006 Aug; 580(18):4533-8. PubMed ID: 16870179
[TBL] [Abstract][Full Text] [Related]
16. Encapsulation in liposomal nanoparticles enhances the immunostimulatory, adjuvant and anti-tumor activity of subcutaneously administered CpG ODN.
de Jong S; Chikh G; Sekirov L; Raney S; Semple S; Klimuk S; Yuan N; Hope M; Cullis P; Tam Y
Cancer Immunol Immunother; 2007 Aug; 56(8):1251-64. PubMed ID: 17242927
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of CpG-DNA against mastitis induced by Escherichia coli infection in a rat model.
Zhu Y; Fan H; Miao J; Zou S
Vet J; 2008 Mar; 175(3):369-78. PubMed ID: 17408997
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of neutrophil elastase inhibitor (FR136706) in lethal acute liver failure induced by D-galactosamine and lipopolysaccharide in rats.
Uchida Y; Kaibori M; Hijikawa T; Ishizaki M; Ozaki T; Tanaka H; Matsui K; Tokuhara K; Kwon AH; Kamiyama Y; Okumura T
J Surg Res; 2008 Mar; 145(1):57-65. PubMed ID: 17936791
[TBL] [Abstract][Full Text] [Related]
19. Decreased intracellular TLR9 confers hyporesponsiveness of RAW264.7 cells to subsequent CpG ODN challenge.
Wei L; Hong Z; Jiang Z; Guofu D; Hongwei C; Liangxi W; Yongling L; Bin L; Ping L
Int Immunopharmacol; 2006 Jun; 6(6):935-46. PubMed ID: 16644479
[TBL] [Abstract][Full Text] [Related]
20. CpG oligodeoxynucleotides protect mice from lethal challenge with Candida albicans via a pathway involving tumor necrosis factor-alpha-dependent interleukin-12 induction.
Choi JH; Ko HM; Park SJ; Kim KJ; Kim SH; Im SY
FEMS Immunol Med Microbiol; 2007 Oct; 51(1):155-62. PubMed ID: 17854477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
